The Cancer Research UK & UCL Cancer Trials Centre (CTC) work with clinical and non-clinical investigators from across the UK to design and conduct national and international clinical trials and research projects to the highest quality and standards. The aim of our work is to improve patient care and clinical practice, and find out more about how cancer grows and becomes resistant to therapies in order to develop more effective treatments. The CTC is a UK Clinical Research Collaboration (UKCRC) registered Clinical Trials Unit. Using a breadth of study designs (observational, and phase I to III clinical trials) CTC studies cover the following key areas:
View our trials portfolio spread across ten main cancer groups.
Book your place on one of our specialist training courses or find out more about UCL postgraduate degrees.
Find out more about working with the CTC on a trial or a research project.
Advice and guidance for patients who are trying to find out more about clinical trials.
What to do if you would like to make a donation to the Cancer Trials Centre
'Introduction to cancer clinical trials for new starters - Thursday19th September 2024'
19/09/2024
'Running a trial from concept to completion - Thursday 3rd October 2024'
03/10/2024
'Entering patients into clinical trials - pre treatment screening and eligibility - Monday 21st October 2024'
21/10/2024
'Cancer treatments and their side effects - compliance and adverse event reporting - Thursday 7th November 2024'
07/11/2024
'Introduction to Cancer Clinical Trials for Statisticians Course 12 & 13 November 2024'
12/11/2024
(Publication) A Prospective Observational Cohort Study for Newly Diagnosed Osteosarcoma Patients in the UK: ICONIC Study Initial Results
Alexa Childs, Craig Gerrand, Bernadette Brennan, Robin Young, Kenneth S. Rankin, Michael Parry, Jonathan Stevenson, Adrienne M. Flanagan, Ra [...]
(Publication) Results from UKALL60+, a phase 2 study in older patients with untreated acute lymphoblastic leukemia.
Patel B, Kirkwood AA, Rowntree CJ, Alapi KZ, Barretta E, Clifton-Hadley L, Creasey T, Lee S, Marks DI, Moorman AV, Morley N, Patrick P, Rana [...]
(Publication) Healthy tissue metabolism assessed by [18F]FDG PET/CT as a marker of prognosis and adverse events in advanced Hodgkin lymphoma patients.
Malaih AA, Kirkwood AA, Johnson P, Radhakrishnan V, Fischer BM, Barrington SF.
Colorectal cancer trial quickly reaches recruitment target
A phase II colorectal cancer trial for patients coordinated by UCL CTC has met its recruitment target within 16 months of opening. The NEOad [...]
Copyright © 2024 UCL | Disclaimer | Freedom of Information | Accessibility | Privacy | Cookies | Contact Us